Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 30, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	106,541	175,818	159,100	-	-	-
Market Cap Growth	-40.98%	10.51%	-	-	-	-
Enterprise Value	103,237	173,015	157,079	-	-	-
Last Close Price	1018.40	1669.95	1502.75	-	-	-
PE Ratio	34.31	47.31	51.64	-	-	-
Forward PE	26.25	41.55	43.46	-	-	-
PS Ratio	9.19	14.65	15.65	-	-	-
PB Ratio	5.83	9.70	10.42	-	-	-
P/TBV Ratio	5.84	9.71	10.42	-	-	-
P/FCF Ratio	-	131.85	88.50	-	-	-
P/OCF Ratio	-	71.90	59.93	-	-	-
PEG Ratio	1.90	1.66	1.43	-	-	-
EV/Sales Ratio	8.91	14.42	15.45	-	-	-
EV/EBITDA Ratio	23.77	33.74	35.82	-	-	-
EV/EBIT Ratio	27.21	37.60	40.62	-	-	-
EV/FCF Ratio	-	129.75	87.37	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.02	0.06	0.09
Debt / EBITDA Ratio	0.00	0.01	0.02	0.09	0.22	0.27
Debt / FCF Ratio	-	0.02	0.05	0.31	1.19	-
Net Debt / Equity Ratio	-0.18	-0.18	-0.18	-0.11	-0.09	-0.11
Net Debt / EBITDA Ratio	-0.76	-0.65	-0.62	-0.39	-0.36	-0.34
Net Debt / FCF Ratio	-	-2.49	-1.51	-1.38	-1.88	2.99
Asset Turnover	-	0.64	0.63	0.60	0.57	0.58
Inventory Turnover	-	1.93	1.66	0.94	0.99	0.88
Quick Ratio	-	4.77	4.58	2.43	2.71	3.92
Current Ratio	-	6.17	6.31	3.79	4.08	5.74
Return on Equity (ROE)	-	22.26%	21.88%	20.06%	16.64%	26.55%
Return on Assets (ROA)	-	15.40%	15.04%	13.26%	11.47%	17.80%
Return on Invested Capital (ROIC)	18.97%	25.28%	24.02%	20.75%	17.83%	30.10%
Return on Capital Employed (ROCE)	-	24.90%	24.80%	22.70%	19.80%	28.10%
Earnings Yield	2.93%	2.11%	1.94%	-	-	-
FCF Yield	-	0.76%	1.13%	-	-	-
Dividend Yield	1.05%	0.64%	0.58%	-	-	-
Payout Ratio	-	24.63%	23.19%	22.31%	40.31%	2.43%
Total Shareholder Return	0.42%	0.64%	0.58%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.